FDA's IMPORT SEIZURE AUTHORITY CHALLENGED
This article was originally published in The Gray Sheet
Executive Summary
FDA's IMPORT SEIZURE AUTHORITY CHALLENGED in an April 18 decision by a New Orleans federal judge that FDA was required to give an importer the opportunity to export mushrooms thought to be misbranded or adulterated before seizing them. The decision could impact on other FDA-regulated products such as devices, drugs and cosmetics.